These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11465348)
1. Cystatin C levels in sera of patients with acute infectious diseases with high C-reactive protein levels. Randers E; Kornerup K; Erlandsen EJ; Hasling C; Danielsen H Scand J Clin Lab Invest; 2001 Jul; 61(4):333-5. PubMed ID: 11465348 [No Abstract] [Full Text] [Related]
2. Cystatin C in heart failure is nothing more than a bystander of glomerular filtration. Codognotto M; Piccoli A; Zaninotto M; Mion M; Vertolli U; Tona F; Boffa GM J Nephrol; 2007; 20(2):219-27. PubMed ID: 17514627 [TBL] [Abstract][Full Text] [Related]
3. Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Werle B; Sauckel K; Nathanson CM; Bjarnadottir M; Spiess E; Ebert W; Abrahamson M Biol Chem; 2003 Feb; 384(2):281-7. PubMed ID: 12675521 [TBL] [Abstract][Full Text] [Related]
4. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Knight EL; Verhave JC; Spiegelman D; Hillege HL; de Zeeuw D; Curhan GC; de Jong PE Kidney Int; 2004 Apr; 65(4):1416-21. PubMed ID: 15086483 [TBL] [Abstract][Full Text] [Related]
5. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Singh D; Whooley MA; Ix JH; Ali S; Shlipak MG Nephrol Dial Transplant; 2007 Apr; 22(4):1087-92. PubMed ID: 17210589 [TBL] [Abstract][Full Text] [Related]
6. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531 [TBL] [Abstract][Full Text] [Related]
7. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis. Samouilidou EC; Grapsa E Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers and the progression of IgA glomerulonephritis. Kaartinen K; Syrjänen J; Pörsti I; Hurme M; Harmoinen A; Pasternack A; Huhtala H; Mustonen J Nephrol Dial Transplant; 2008 Apr; 23(4):1285-90. PubMed ID: 17986475 [TBL] [Abstract][Full Text] [Related]
9. Estimating glomerular filtration rate by measurement of cystatin C serum concentrations: a comparison with chrome-EDTA clearance. Garlipp CR; Bottini PV; Queiroz RR; Afaz SH Clin Chim Acta; 2008 Jul; 393(2):125-7. PubMed ID: 18454938 [No Abstract] [Full Text] [Related]
10. Twenty-four hour variations of cystatin C and total cysteine proteinase inhibitory activity in sera from healthy subjects. Cimerman N; Brguljan PM; Krasovec M; Suskovic S; Kos J Clin Chim Acta; 2000 Jan; 291(1):89-95. PubMed ID: 10612720 [No Abstract] [Full Text] [Related]
11. Serum cystatin C in patients with myeloma. Finney H; Williams AH; Price CP Clin Chim Acta; 2001 Jul; 309(1):1-6. PubMed ID: 11407999 [TBL] [Abstract][Full Text] [Related]
12. Serum cystatin C as a marker of kidney dysfunction in an elderly population. Wasén E; Suominen P; Isoaho R; Mattila K; Virtanen A; Kivelä SL; Irjala K Clin Chem; 2002 Jul; 48(7):1138-40. PubMed ID: 12089199 [No Abstract] [Full Text] [Related]
13. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Jernberg T; Lindahl B; James S; Larsson A; Hansson LO; Wallentin L Circulation; 2004 Oct; 110(16):2342-8. PubMed ID: 15477399 [TBL] [Abstract][Full Text] [Related]
14. Reference intervals for serum cystatin C in healthy Mexican adults. Croda-Todd M; Juarez E; Hernández P; Flores G; Rivera G; Bocanegra-Garcia V Clin Chem Lab Med; 2007; 45(7):925-7. PubMed ID: 17617040 [No Abstract] [Full Text] [Related]
15. Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies. Pergande M; Jung K Clin Chem; 1993 Sep; 39(9):1885-90. PubMed ID: 8375065 [TBL] [Abstract][Full Text] [Related]
16. Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma. Mulaomerović A; Halilbasić A; Cickusić E; Zavasnik-Bergant T; Begić L; Kos J Cancer Lett; 2007 Apr; 248(2):192-7. PubMed ID: 16945481 [TBL] [Abstract][Full Text] [Related]
17. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Keller CR; Odden MC; Fried LF; Newman AB; Angleman S; Green CA; Cummings SR; Harris TB; Shlipak MG Kidney Int; 2007 Feb; 71(3):239-44. PubMed ID: 17183246 [TBL] [Abstract][Full Text] [Related]
18. Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein. Shinkai S; Chaves PH; Fujiwara Y; Watanabe S; Shibata H; Yoshida H; Suzuki T Arch Intern Med; 2008 Jan; 168(2):200-6. PubMed ID: 18227369 [TBL] [Abstract][Full Text] [Related]
19. Cystatin C of pleural effusion as a novel diagnostic aid in pleural diseases of different aetiologies. Domej W; Tilz GP; Földes-Papp Z; Demel U; Rabold T; Holzer H Clin Sci (Lond); 2002 Mar; 102(3):373-80. PubMed ID: 11869179 [TBL] [Abstract][Full Text] [Related]
20. Determination of serum cystatin C: biological variation and reference values. Galteau MM; Guyon M; Gueguen R; Siest G Clin Chem Lab Med; 2001 Sep; 39(9):850-7. PubMed ID: 11601685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]